News
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...
New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...
4d
News Medical on MSNNew TB drugs show promise with fewer side effects than linezolidThe drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...
A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the ...
The Central government may soon restrict the distribution of new anti-tuberculosis (TB) drugs bedaquiline, delamanid, pretomanid and rifapentine in the open market, allowing conditional access through ...
TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...
Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...
A new partnership, of pharma companies and research institutions, has been launched to speed the discovery of new, more effective, drugs for patients with tuberculosis. The TB Drug Accelerator, a ...
Tuberculosis. Read the latest research news on tuberculosis, including a quick new TB test, new TB treatment options, and the latest news on tuberculosis infections.
Puducherry leads in TB screening through Family Adoption Programme, involving medical students and advanced diagnostic methods for early detection.
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results